Latest Interviews
Showing 1–3 of 3 interview transcripts.
Clear all filters- Y Combinator3 min
Celebrating 20 Years of Y Combinator
Paul Graham, Jessica Livingston, Trevor Blackwell, Robert Morris
Originating from a collaboration between Paul and a co-founder to address flaws in traditional investing, Y Combinator adopted a batch funding model for eight startups that was rapidly validated as highly effective. Recruiting early co-founders like Robert Morris and Trevor Blackwell to fill their inexperience in angel investing, the program evolved from a small project into a persistent, university-like institution designed to operate for centuries. With a legacy goal of improving lives and the world, the initiative continues to drive enthusiasm through extensive educational outreach and initiatives like Startup School while maintaining its core mission of launching new ventures.
- Y Combinator1 min
Paul Graham: What are some common mistakes founders make?
Many founders avoid validating their isolated visions through user contact due to a fear of rejection or the tedious nature of sales, often delaying product launches until they face humiliating feedback. The speaker argues that the most effective strategy involves identifying individuals willing to pay for a specific solution they personally experience, rather than building based on hypothetical needs. Ultimately, embracing direct engagement with the real world is presented as the only viable path to iteration and product improvement.
- Y Combinator2 min
Paul Graham: When should you launch your startup?
This framework argues that the risk of delaying a product launch exceeds the risk of launching early, establishing the "minimum quantum of utility" as the sole readiness criterion where at least one user gains a new capability. A launch is deemed premature only if no value is derived, while securing ten "super excited" core users, as suggested by Paul Bouquet, satisfies the threshold regardless of broader market indifference. Consequently, the strategy prioritizes deep enthusiasm from a small initial group over broad market approval to validate a product's viability.